SG Americas Securities, LLC - SALIX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$5,650,000
-26.3%
22,8000.0%0.03%
-37.8%
Q3 2014$7,662,000
+25.5%
22,8000.0%0.04%
+28.6%
Q2 2014$6,103,00022,8000.04%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Baker Brothers Advisors 219,440,000$431,748,0006.08%
SYMPHONY ASSET MANAGEMENT LLC 12,727,000$25,040,0001.83%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 21,000,000$41,318,0000.49%
DINSMORE CAPITAL MANAGEMENT CO/NJ 600,000$1,184,0000.48%
SHENKMAN CAPITAL MANAGEMENT INC 200,000$395,0000.04%
Citadel Advisors 11,000,000$21,696,0000.03%
PEAK6 Group LLC 15,000$2,951,0000.02%
FRANKLIN RESOURCES INC 17,290,000$34,071,0000.02%
LORD, ABBETT & CO. LLC 3,243,000$6,397,0000.01%
EULAV Asset Management 123,000$242,0000.01%
View complete list of SALIX PHARMACEUTICALS INC shareholders